Andrew Hodson

442 total citations
18 papers, 164 citations indexed

About

Andrew Hodson is a scholar working on Immunology, Pathology and Forensic Medicine and Ecology, Evolution, Behavior and Systematics. According to data from OpenAlex, Andrew Hodson has authored 18 papers receiving a total of 164 indexed citations (citations by other indexed papers that have themselves been cited), including 8 papers in Immunology, 6 papers in Pathology and Forensic Medicine and 6 papers in Ecology, Evolution, Behavior and Systematics. Recurrent topics in Andrew Hodson's work include T-cell and Retrovirus Studies (8 papers), Lymphoma Diagnosis and Treatment (6 papers) and Vector-Borne Animal Diseases (6 papers). Andrew Hodson is often cited by papers focused on T-cell and Retrovirus Studies (8 papers), Lymphoma Diagnosis and Treatment (6 papers) and Vector-Borne Animal Diseases (6 papers). Andrew Hodson collaborates with scholars based in United Kingdom, Canada and South Africa. Andrew Hodson's co-authors include Reuben M. Cherniack, Graham P. Taylor, Paul Fields, Kate Cwynarski, Kirit M. Ardeshna, Antonio Pagliuca, Silvia Montoto, Naheed Mir, Estella Matutes and Siobhan Crichton and has published in prestigious journals such as Journal of Clinical Oncology, SHILAP Revista de lepidopterología and Blood.

In The Last Decade

Andrew Hodson

18 papers receiving 157 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Andrew Hodson United Kingdom 6 92 72 67 48 34 18 164
Kazuko Doi Japan 6 33 0.4× 17 0.2× 9 0.1× 13 0.3× 29 0.9× 7 78
Jane A. Dobbin Brazil 3 24 0.3× 15 0.2× 11 0.2× 6 0.1× 13 0.4× 6 97
Beate Kruse Germany 4 53 0.6× 8 0.1× 13 0.2× 4 0.1× 16 0.5× 6 91
Denis Miyashiro Brazil 9 60 0.7× 10 0.1× 5 0.1× 76 1.6× 43 1.3× 31 201
Müge Aydın Tufan Türkiye 6 9 0.1× 18 0.3× 22 0.3× 3 0.1× 10 0.3× 14 107
T. Yamamoto Japan 2 21 0.2× 9 0.1× 7 0.1× 12 0.3× 5 0.1× 4 47
L Riley United States 4 67 0.7× 7 0.1× 12 0.2× 4 0.1× 84 2.5× 6 129
Yıldız Aydın Türkiye 8 13 0.1× 4 0.1× 4 0.1× 19 0.4× 28 0.8× 39 176
Yilin China 2 308 3.3× 41 0.6× 11 0.2× 13 0.4× 3 331
C. Fite France 8 26 0.3× 7 0.1× 2 0.0× 43 0.9× 3 0.1× 15 141

Countries citing papers authored by Andrew Hodson

Since Specialization
Citations

This map shows the geographic impact of Andrew Hodson's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Andrew Hodson with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Andrew Hodson more than expected).

Fields of papers citing papers by Andrew Hodson

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Andrew Hodson. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Andrew Hodson. The network helps show where Andrew Hodson may publish in the future.

Co-authorship network of co-authors of Andrew Hodson

This figure shows the co-authorship network connecting the top 25 collaborators of Andrew Hodson. A scholar is included among the top collaborators of Andrew Hodson based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Andrew Hodson. Andrew Hodson is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

18 of 18 papers shown
1.
Lentell, Isabel, Brendan O’Sullivan, Andrew Hodson, et al.. (2022). Managing relapsed refractory lymphoma with palliative oral chemotherapy: A multicentre retrospective study. SHILAP Revista de lepidopterología. 3(4). 1316–1320. 2 indexed citations
2.
3.
Hounsome, Luke, Toby A. Eyre, Robin Ireland, et al.. (2021). Diffuse large B cell lymphoma (DLBCL) in patients older than 65 years: analysis of 3 year Real World data of practice patterns and outcomes in England. British Journal of Cancer. 126(1). 134–143. 21 indexed citations
4.
5.
Collins, Anne T., Chandan Saha, Vidyarani Shyamsundar, et al.. (2017). Advanced Hodgkin lymphoma in the east of England cancer network: A 10‐year comparative analysis of outcomes for ABVD and escalated‐BEACOPP treated patients aged 16 to 59. Hematological Oncology. 35(S2). 318–319. 1 indexed citations
6.
Phillips, Elizabeth H., Andrew Hodson, Olivier Hermine, Ali Bazarbachi, & Kate Cwynarski. (2016). Striving to cure adult T-cell leukaemia/lymphoma: a role for allogeneic stem cell transplant?. Bone Marrow Transplantation. 51(12). 1549–1555. 11 indexed citations
7.
Bloxam, David L., et al.. (2015). Extramedullary acute myeloid leukaemia: isolated leukaemic pleural and pericardial effusions without marrow disease. British Journal of Haematology. 171(3). 295–295. 1 indexed citations
8.
9.
Melamed, Anat, Nicolas Gillet, Andrew Hodson, et al.. (2014). The potential of CD127 as a prognostic and residual disease marker in chronic adult T cell leukaemia/lymphoma. Retrovirology. 11(S1). 1 indexed citations
10.
Hodson, Andrew, Lucy Cook, Nicolas Gillet, et al.. (2014). Haematological and molecular responses in patients with chronic ATLL treated with zidovudine and interferon-α. Retrovirology. 11(S1). 4 indexed citations
11.
Mugisha, Joseph, Katherine Donegan, Sarah Fidler, et al.. (2012). Mean Corpuscular Volume as a Marker for Adherence to Zidovudine-Containing Therapy in HIV-Infected Adults. The Open AIDS Journal. 6(1). 45–52. 4 indexed citations
12.
Hodson, Andrew, Daniel J. Laydon, Barbara J. Bain, Paul Fields, & Graham P. Taylor. (2012). Pre-morbid human T-lymphotropic virus type I proviral load, rather than percentage of abnormal lymphocytes, is associated with an increased risk of aggressive adult T-cell leukemia/lymphoma. Haematologica. 98(3). 385–388. 19 indexed citations
13.
Grigoropoulos, Nicholas F., Andrew Hodson, Ashley Shaw, et al.. (2012). Interim PET Scan Does Not Predict Outcome in Primary Mediastinal B Cell Lymphoma Treated with R DA EPOCH. Blood. 120(21). 4846–4846. 3 indexed citations
14.
Hodson, Andrew, Maria Antonietta Demontis, Nicolas Gillet, et al.. (2011). First line treatment of acute and chronic ATLL with zidovudine (AZT) and interferon alpha (IFN-α): haematological and molecular responses. Retrovirology. 8(S1). 1 indexed citations
15.
Hodson, Andrew, Siobhan Crichton, Silvia Montoto, et al.. (2011). Use of Zidovudine and Interferon Alfa With Chemotherapy Improves Survival in Both Acute and Lymphoma Subtypes of Adult T-Cell Leukemia/Lymphoma. Journal of Clinical Oncology. 29(35). 4696–4701. 55 indexed citations
16.
Hodson, Andrew, Silvia Montoto, Naheed Mir, et al.. (2010). Addition of Anti-Viral Therapy to Chemotherapy Improves Overall Survival In Acute and Lymphomatous Adult T-Cell Leukaemia/Lymphoma (ATLL). Blood. 116(21). 3961–3961. 5 indexed citations
17.
18.
Cherniack, Reuben M. & Andrew Hodson. (1963). Compliance of the chest wall in chronic bronchitis and emphysema. Journal of Applied Physiology. 18(4). 707–711. 22 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Kazuko Doi Breakdown of academic impact, for papers by Jane A. Dobbin Breakdown of academic impact, for papers by Beate Kruse Breakdown of academic impact, for papers by Denis Miyashiro Breakdown of academic impact, for papers by Müge Aydın Tufan Breakdown of academic impact, for papers by T. Yamamoto Breakdown of academic impact, for papers by L Riley Breakdown of academic impact, for papers by Yıldız Aydın Breakdown of academic impact, for papers by Yilin Breakdown of academic impact, for papers by C. Fite
Rankless by CCL
2026